NYSEMKT: FOXOFoxo Technologies Inc Stock
$0.08-0.03 (-27.27%)
Updated Apr 17, 2025
FOXO Price
$0.08
Fair Value Price
N/A
Market Cap
$3.01M
52 Week Low
$0.07
52 Week High
$1.30
P/E
-0.09x
P/B
0.57x
P/S
1.05x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.05M
Earnings
-$12.41M
Gross Margin
38.7%
Operating Margin
-209.7%
Profit Margin
-332.7%
Debt to Equity
6.84
Operating Cash Flow
-$3B
Beta
1.47
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FOXO's potential to beat the market
- FOXO doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
FOXO
RankedUnranked of 44
RankedUnranked of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $149.00 | A | |
| $62.37 | A | |
| $1.42 | B |
Be the first to know about important FOXO news, forecast changes, insider trades & much more!
FOXO News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FOXO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FOXO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FOXO is good value based on its book value relative to its share price (0.57x), compared to the US Health Information Services industry average (3.39x)
P/B vs Industry Valuation
FOXO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more FOXO due diligence checks available for Premium users.
Valuation
FOXO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.09x
Industry
11.14x
Market
27.98x
FOXO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.57x
Industry
3.39x
FOXO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FOXO's financial health
Profit margin
Revenue
$2.8M
Net Income
-$6.8M
Profit Margin
-241.6%
FOXO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FOXO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$41.7M
Liabilities
$36.4M
Debt to equity
6.84
FOXO's short-term liabilities ($32.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FOXO's long-term liabilities ($3.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FOXO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.8B
Investing
$13.3M
Financing
$2.9B
FOXO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FOXO vs Health Information Service Stocks
Foxo Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.